| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |